-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $81

Benzinga·05/13/2026 18:07:17
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target from $69 to $81.